One review demonstrated cerebral hypoperfusion, and glucose hypometabolism trigger neuroinflammation and oxidative stress that in turn decrease nitric oxide, upregulating amyloid, and tau in AD (Daulatzai, 2017). The gene discussed is MAPT; the disease is Alzheimer disease.